Clinical Use of Apolipoprotein Quantitation
Authors: A. Myron Johnson
Journal: Annals of Internal Medicine (1995)

Letters1 January 1995Clinical Use of Apolipoprotein QuantitationA. Myron Johnson, MD, Wendy Y. Craig, MD, and Thomas B. Ledue, BAA. Myron Johnson, MDThe Moses H. Cone Memorial Hospital; Greensboro, NC 27401-1020Foundation for Blood Research; Scarborough, ME 04070-0190Search for more papers by this author, Wendy Y. Craig, MDThe Moses H. Cone Memorial Hospital; Greensboro, NC 27401-1020Foundation for Blood Research; Scarborough, ME 04070-0190Search for more papers by this author, and Thomas B. Ledue, BAThe Moses H. Cone Memorial Hospital; Greensboro, NC 27401-1020Foundation for Blood Research; Scarborough, ME 04070-0190Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-122-1-199501010-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The recent review of plasma apolipoproteins by Rader and colleagues [1] was thorough and generally excellent. We feel, however, that several points deserve comment. First, there are now international reference materials for apo A-I and apo B [2]. Manufacturers of immunochemical reagents and their related assay kits are currently converting to the values assigned to these reference materials. Admittedly, some differences will persist among methods and laboratories, but these should be substantially reduced after everyone has converted to the new values.Second, the authors state that the British United Provident Association (BUPA) data [4] do not support ...References1. Rader DJ, Hoeg JM, Brewer HB Jr. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994; 120:1012-25. Google Scholar2. Marcovina SM, Albers JJ, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin Chem. 1993; 39:773-81. Google Scholar3. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem. 1994; 40:586-92. Google Scholar4. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet. 1994; 343:75-9. Google Scholar Author, Article, and Disclosure InformationAuthors: A. Myron Johnson, MD; Wendy Y. Craig, MD; Thomas B. Ledue, BAAffiliations: The Moses H. Cone Memorial Hospital; Greensboro, NC 27401-1020Foundation for Blood Research; Scarborough, ME 04070-0190 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 January 1995Volume 122, Issue 1 Page: 69-70 Keywords Apolipoproteins Blood plasma Cholesterol Coronary heart disease Death rates High density lipoprotein Lipids Lipoproteins Longitudinal studies Stable coronary artery disease ePublished: 15 August 2000 Issue Published: 1 January 1995 Copyright & PermissionsCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...